BDBM200331 US9227956, 15b

SMILES: CCOC(=O)O[C@H](C)OC(=O)c1c(cnn1C)-c1ccc(cc1)C(=O)N([C@@H]1CCCNC1)c1ncccc1Cl

InChI Key: InChIKey=DUHCQXCKCLIECZ-YLJYHZDGSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 200331   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Proprotein convertase subtilisin/kexin type 9 (PCSK9) (Homo sapiens (Human))	BDBM200331 (US9227956, 15b) Show SMILES CCOC(=O)O[C@H](C)OC(=O)c1c(cnn1C)-c1ccc(cc1)C(=O)N([C@@H]1CCCNC1)c1ncccc1Cl |r| Show InChI InChI=1S/C27H30ClN5O6/c1-4-37-27(36)39-17(2)38-26(35)23-21(16-31-32(23)3)18-9-11-19(12-10-18)25(34)33(20-7-5-13-29-15-20)24-22(28)8-6-14-30-24/h6,8-12,14,16-17,20,29H,4-5,7,13,15H2,1-3H3/t17-,20-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description In order to eliminate the permeability barrier inherent to the WT7 and SCHH cell-based assays a cell-free system was also established to access compo...				US Patent US9227956 (2016) BindingDB Entry DOI: 10.7270/Q20R9N7M
					More data for this Ligand-Target Pair
Proprotein convertase subtilisin/kexin type 9 (PCSK9) (Homo sapiens (Human))	BDBM200331 (US9227956, 15b) Show SMILES CCOC(=O)O[C@H](C)OC(=O)c1c(cnn1C)-c1ccc(cc1)C(=O)N([C@@H]1CCCNC1)c1ncccc1Cl |r| Show InChI InChI=1S/C27H30ClN5O6/c1-4-37-27(36)39-17(2)38-26(35)23-21(16-31-32(23)3)18-9-11-19(12-10-18)25(34)33(20-7-5-13-29-15-20)24-22(28)8-6-14-30-24/h6,8-12,14,16-17,20,29H,4-5,7,13,15H2,1-3H3/t17-,20-/m1/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.07E+4	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. US Patent					Assay Description An in-vitro AlphaLISA assay (Perkin Elmer) was developed in order to quantitate the level of PCSK9 secreted into the cell culture media following com...				US Patent US9227956 (2016) BindingDB Entry DOI: 10.7270/Q20R9N7M
					More data for this Ligand-Target Pair